1. Home
  2. ABEO vs LOKV Comparison

ABEO vs LOKV Comparison

Compare ABEO & LOKV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Abeona Therapeutics Inc.

ABEO

Abeona Therapeutics Inc.

HOLD

Current Price

$5.34

Market Cap

307.5M

Sector

Health Care

ML Signal

HOLD

Logo Live Oak Acquisition Corp. V Class A Ordinary Shares

LOKV

Live Oak Acquisition Corp. V Class A Ordinary Shares

HOLD

Current Price

$10.45

Market Cap

300.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABEO
LOKV
Founded
1974
2024
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
307.5M
300.4M
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
ABEO
LOKV
Price
$5.34
$10.45
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$20.00
N/A
AVG Volume (30 Days)
1.0M
133.1K
Earning Date
05-14-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
165.16
N/A
EPS
1.01
N/A
Revenue
$2,998,000.00
N/A
Revenue This Year
$1,024.31
N/A
Revenue Next Year
$145.42
N/A
P/E Ratio
$5.34
N/A
Revenue Growth
258.18
N/A
52 Week Low
$4.00
$9.88
52 Week High
$7.54
$11.46

Technical Indicators

Market Signals
Indicator
ABEO
LOKV
Relative Strength Index (RSI) 56.63 64.97
Support Level $5.24 $10.24
Resistance Level $5.62 $10.49
Average True Range (ATR) 0.24 0.02
MACD 0.03 -0.00
Stochastic Oscillator 55.38 66.67

Price Performance

Historical Comparison
ABEO
LOKV

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.

About LOKV Live Oak Acquisition Corp. V Class A Ordinary Shares

Live Oak Acquisition Corp V is a blank check company.

Share on Social Networks: